Abstract
Posterior reversible encephalopathy syndrome (PRES) is associated with a specific disorder of cerebrovascular autoregulation of multiple etiologies. This syndrome had been subsequently described in numerous medical conditions, including hypertensive encephalopathy, pre-eclampsia and the use with immunosuppressive drugs. Here, we report a child suffering from Langerhans cell histocytosis developing into PRES following immunosuppressive therapy. Symptoms and neuroimaging abnormalities were complete resolution subsequent to the withdrawal of cyclosporine. Although PRES is rarely seen among children, it should always be considered in the differential diagnosis of acute neurological illness, especially undergoing immunosuppressive therapy.
Abbreviations
- PRES:
-
posterior reversible encephalopathy syndrome
- MRI:
-
magnetic resonance imaging
- FLAIR:
-
fluid-attenuated inversion recovery
- DWI:
-
diffusion-weighted images
- ADC:
-
apparent diffusion coefficient
- LCH:
-
Langerhans cell histocytosis
- CsA:
-
cyclosporine
References
Casey SO, Sampaio RC, Michel E, Truwit CL (2000) Posterior reversible encephalopathy syndrome: Utility of fluid-attenuated inversion recovery MR imaging in the detection of cortical and subcortical lesions. Am J Neuroradiol 21:1199–1206
Covarrubias DJ, Luetmer PH, Campeau NG (2002) Posterior reversible encephalopathy syndrome:prognostic utility of quantitative diffusion-weighted MR images. Am J Neuroradiol 23:1038–1048
Engelter ST, Provenzale JM, Petrella JR (2000) Assessment of vasogenic edema in eclampsia using diffusion imaging. Neuroradiology 42:818–820
Hinchey J, Chaves C, Appignani B, Breen J, Pao L, Wang A, Pessin MS, Lamy C, Mas JL, Caplan LR (1996) A reversible posterior leucoencephalopathy syndrome. N Engl J Med 334:494–500
Lamy C, Oppenheim C, Meder JF, Mas JL (2004) Neuroimaging in posterior reversible encephalopathy syndrome. J Neuroimaging 14:89–96
Ozcakar ZB, Ekim M, Fitoz S, Teber S, Hizel S, Acar B, Yuksel S, Yalcinkaya F (2004) Hypertension induced reversible posterior leukoencephalopathy syndrome: a report of two cases. Eur J Pediatr 163:728–730
Provenzale JM, Petrella JR, Cruz LCH, Wong JC, Engelter S, Barboriak DP (2001) Quantitative assessment of diffusion abnormalities in posterior reversible encephalopathy syndrome. Am J Neuroradiol 22:1455–1461
Sloane JP, Lwin KY, Gore ME, Powles RL, Smith JF (1985) Disturbance of blood–brain barrier after bone–marrow transplantation. Lancet 2:280–281
Strandgarrd S, Paulson OB (1984) Cerebral autoregulation. Stroke 15:413–416
Teive HA, Brandi IV, Camargo CH, Bittencourt MA, Bonfim CM, Friedrich ML, de Medeiros CR, Werneck LC, Pasquini R (2001) Reversible posterior leucoencephalopathy syndrome associated with bone marrow transplantation. Arq Neuropsiquiatr 59:784–789
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lai, CC., Chen, SJ., Lien, SH. et al. Posterior reversible encephalopathy in a child with Langerhans cell histiocytosis following allogeneic PBSCT treatment with cyclosporine. Eur J Pediatr 167, 817–820 (2008). https://doi.org/10.1007/s00431-007-0564-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00431-007-0564-2